GOLDMAN SACHS GROUP INC - KALEIDO BIOSCIENCES INC ownership

KALEIDO BIOSCIENCES INC's ticker is KLDO and the CUSIP is 483347100. A total of 72 filers reported holding KALEIDO BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KALEIDO BIOSCIENCES INC
ValueSharesWeighting
Q4 2021$43,000
-78.8%
18,060
-51.4%
0.00%
Q3 2021$203,000
+49.3%
37,149
+103.9%
0.00%
Q2 2021$136,000
+8.8%
18,220
+18.4%
0.00%
Q1 2021$125,0000.0%15,383
+11.6%
0.00%
Q4 2020$125,000
-77.7%
13,778
-87.7%
0.00%
Q4 2019$561,000
-21.9%
111,706
+125.6%
0.00%
Q1 2019$718,00049,5250.00%
Other shareholders
KALEIDO BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 19,575,710$158,562,0002.54%
HARBOURVEST PARTNERS LLC 1,833,832$14,854,0001.99%
Trustees of Columbia University in the City of New York 150,150$1,216,0001.47%
Palo Alto Investors LP 786,400$6,370,0000.36%
Artal Group S.A. 500,500$4,054,0000.07%
EXANE DERIVATIVES 21,333$172,790,0000.05%
FEDERATED HERMES, INC. 825,000$6,683,0000.01%
Johnson Midwest Financial, LLC 745$6,0000.01%
Cerity Partners LLC 18,500$150,0000.00%
FMR LLC 6,370,018$51,597,0000.00%
View complete list of KALEIDO BIOSCIENCES INC shareholders